Clinical Trial Update: A Long-term Extension Study of Ustekinumab in Pediatric Participants [Phase 3]

View source ↗

Summary

Long-term extension study of ustekinumab in pediatric participants (Phase 3) for Crohn disease, ulcerative colitis, and related psoriatic arthritis indications;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriatic Arthritis
• Ulcerative Colitis

Drugs mentioned

• USTEKINUMAB (USTEKINUMAB)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn Disease, Colitis, Ulcerative | Phase 3 | Status: ACTIVE_NOT_RECRUITING